Drug Shortage Report for TARO-BORTEZOMIB
Report ID | 215073 |
Drug Identification Number | 02511932 |
Brand name | TARO-BORTEZOMIB |
Common or Proper name | BORTEZOMIB |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | BORTEZOMIB |
Strength(s) | 2.5MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS |
Packaging size | 2.5 |
ATC code | L01XG |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-12-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-01-05 |
Company comments | Import Ban for manufacturing site in Halol, India |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-01-05 | French | Compare |
v1 | 2024-01-05 | English | Compare |
Showing 1 to 2 of 2